A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19.
Pedro LandeteOlga-Adriana Caliman-SturdzaJose Antonio Lopez-MartinLiliana Lucia PreoțescuMihaela-Catalina LucaAnastasia KotanidouPaula VillaresShirley-Patricia IglesiasPablo Guisado-VascoElena-Maria Saiz-LouMaria Del Carmen Farinas-AlvarezEsperanza Merino de LucasEduardo Perez-AlbaJose-Miguel CisnerosVicente EstradaCarmen Hidalgo-TenorioGaryphallia PoulakouMiguel Torralba González de SusoJesus FortunPaula Garcia-OcanaAdrien LemaignenMiguel Marcos-MartinMaria MolinaRoger ParedesMaria Teresa Perez-RodriguezDimitar RaevPablo RyanFernanda MeiraJavier GomezNadia TorresDiego Lopez-MendozaJose JimenoJose-Felipe VaronaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
This trial has been funded by Pharmamar, S.A. (Madrid, Spain).